IRIS
FRANCESCHI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.923
AS - Asia 1.840
EU - Europa 800
SA - Sud America 210
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 49
OC - Oceania 1
Totale 4.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.864
SG - Singapore 665
CN - Cina 567
VN - Vietnam 277
IE - Irlanda 214
SE - Svezia 210
BR - Brasile 165
HK - Hong Kong 101
TR - Turchia 69
DE - Germania 67
FR - Francia 56
NL - Olanda 49
ZA - Sudafrica 48
IT - Italia 44
FI - Finlandia 43
BD - Bangladesh 34
GB - Regno Unito 34
CA - Canada 32
IN - India 32
RU - Federazione Russa 21
CI - Costa d'Avorio 20
AR - Argentina 13
MX - Messico 12
PL - Polonia 11
PK - Pakistan 10
JP - Giappone 9
MA - Marocco 9
VE - Venezuela 9
UA - Ucraina 8
IL - Israele 7
IQ - Iraq 7
IR - Iran 7
PH - Filippine 7
RO - Romania 7
EC - Ecuador 6
UZ - Uzbekistan 6
BE - Belgio 5
EG - Egitto 5
EU - Europa 5
AZ - Azerbaigian 4
CL - Cile 4
ID - Indonesia 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
PY - Paraguay 4
TH - Thailandia 4
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ES - Italia 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
KR - Corea 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
BO - Bolivia 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
SR - Suriname 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.876
Salva come PNG Salva come JPEG
Città #
Chandler 354
Singapore 334
Ashburn 295
Dublin 214
Santa Clara 196
San Jose 141
Beijing 125
Hong Kong 95
Ho Chi Minh City 89
Dearborn 74
Nanjing 62
Shanghai 58
Izmir 54
Hanoi 52
Johannesburg 48
Boardman 47
Princeton 42
Los Angeles 37
Dallas 36
Lauterbourg 36
Helsinki 34
Munich 33
Shenyang 32
Wilmington 27
New York 23
Kunming 21
Nanchang 21
Abidjan 20
Hebei 20
Jiaxing 18
San Mateo 18
Da Nang 17
Frankfurt am Main 17
Moscow 16
Tianjin 15
Changsha 14
Guangzhou 13
Toronto 13
São Paulo 11
Columbus 10
Jinan 10
Ann Arbor 9
Buffalo 9
Kocaeli 9
Tokyo 9
Turku 9
Biên Hòa 8
Hangzhou 7
Hefei 7
Pune 7
Seattle 7
Augusta 6
Bremen 6
Brooklyn 6
Cambridge 6
Chennai 6
Council Bluffs 6
Fremont 6
Orem 6
Stockholm 6
Timisoara 6
Warsaw 6
Baghdad 5
Belo Horizonte 5
Brussels 5
Draper 5
Edinburgh 5
Grafing 5
Haiphong 5
Hải Dương 5
London 5
Milan 5
Norwalk 5
Phoenix 5
Tashkent 5
Andover 4
Baku 4
Bexley 4
Can Tho 4
Cotia 4
Leawood 4
Montreal 4
Mumbai 4
Nairobi 4
Ningbo 4
Parma 4
Rio de Janeiro 4
Salvador 4
Shijiazhuang 4
Taizhou 4
Uberlândia 4
Wuhan 4
Asunción 3
Bangkok 3
Bishkek 3
Boston 3
Brasília 3
Bridgetown 3
Budapest 3
Caracas 3
Totale 3.096
Salva come PNG Salva come JPEG
Nome #
Helicobacter pylori infection in asymptomatic elderly subjects living at home or in a nursing home: effects on gastric function and nutritional status 161
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 161
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 161
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 154
P.02.5: PPI Test for Diagnosis of Body Atrophic Gastritis: A Prospective Study 143
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 142
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 139
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 135
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 133
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 132
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 130
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 129
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 129
P.02.2: Improvement of Symptoms in Patients Affected by Chronic Athrophic Gastritis: A 2 Years Prospective Study by using L-Cysteine (Acetium™) 129
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 126
P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population 126
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS 124
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases 124
The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people 122
P.02.10: Bismuth-Containing Quadruple Therapy in Patients Infected by Helicobacter Pylori: A First Real Life Italian Experience 120
Serum Pepsinogen II as a non-invasive marker for diagnosis of Helicobacter pylori infection: a prospective study in a cohort of dyspeptic patients 119
P.07.2: Natural History of Symptomatic Uncomplicated Diverticular Disease: A 13-Year Prospective Study 116
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 116
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test 115
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 114
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS 113
La terapia delle malattie acido-correlate nell'anziano 112
P.04.3 SERUM PEPSINOGEN II LEVELS AND IGG ANTI HELICOBACTER PYLORI ANTIBODIES MAY REPRESENT A NON-INVASIVE METHOD FOR THE DIAGNOSIS AND MONITORING OF H PYLORI-RELATED GASTRITIS 111
P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients 111
P.14.3 A NON-INVASIVE MONITORING OF THE FUNCTIONALITY OF GASTRIC MUCOSA (GASTROPANEL TEST) IN DYSPEPTIC PATIENTS: A PRELIMINARY STUDY 110
The cure for Helicobacter pylori ((HP) infection with double or triple omeprazole-based therápies in the elderly: Effects on eradication rate, chronic gastritis and serum anti-HP antibodies and pepsinogens 109
P.02.19: Prevalence of H. Pylori Infection, Chronic Atrophic Gastritis and Reflux Disease in a Primary Care Population of North-East Italy with Serum Biomarker Panel (Gastropanel®) 105
P.16.3 IMPROVEMENT OF APPROPRIATENESS AND REDUCTION OF WAITING LISTS CONCERNING UPPER GI ENDOSCOPY OUTPATIENTS: A SINGLE-CENTRE PROSPECTIVE STUDY 102
P.02.15: The Role of Gastropanel in the Evaluation of the Appropriateness of Proton PUMP Inhibitor (PPI)-Therapy Prescription in a Primary Care Population 91
Prevalence of H. pylori resistance to antibiotics in North-East Italy: A multicentered study 88
P.04.25 ROLE OF CYP2C19*17 AND CYP2C19*2 IN THE RESPONSE TO PROTON PUMP INHIBITORS TREATMENT IN PATIENTS WITH ESOPHAGITIS 86
Role of proton pump inhibitors in the prevention of upper GI bleeding in elderly acute and chronic NSAID users 84
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 83
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly 83
The effect of aging on oro-cecal transit time in normal subjects and patients with gallstone disease 82
P.17.5 UPPER GI BLEEDING: CLINICAL AND DEMOGRAPHIC FEATURES IN AN ENDOSCOPIC POPULATION STUDY OF NORTH-EAST ITALY 77
P.09.9 DIAGNOSTIC ACCURACY OF AGE AND ALARM SYMPTOMS FOR UPPER GI MALIGNANCY IN PATIENTS WITH DYSPEPSIA IN AN ENDOSCOPIC UNIT 62
null 10
Totale 4.919
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.023
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022183 0 0 0 9 20 5 0 16 6 17 16 94
2022/2023924 72 114 68 93 58 122 1 84 273 3 32 4
2023/2024249 14 26 4 9 23 56 4 26 12 12 32 31
2024/20251.085 36 52 66 35 139 139 37 46 176 95 80 184
2025/20261.774 200 138 161 144 310 117 160 37 269 132 51 55
2026/202750 38 12 0 0 0 0 0 0 0 0 0 0
Totale 4.919